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Precise genome editing involves homologous recombination between donor DNA and
chromosomal sequences subjected to double-stranded DNA breaks made by programmable
nucleases. Ideally, genome editing should be efficient, specific, and accurate. However,
besides constituting potential translocation-initiating lesions, double-stranded DNA breaks
(targeted or otherwise) are mostly repaired through unpredictable and mutagenic non-
homologous recombination processes. Here, we report that the coordinated formation of
paired single-stranded DNA breaks, or nicks, at donor plasmids and chromosomal target sites
by RNA-guided nucleases based on CRISPR-Cas9 components, triggers seamless homology-
directed gene targeting of large genetic payloads in human cells, including pluripotent stem
cells. Importantly, in addition to significantly reducing the mutagenicity of the genome
modification procedure, this in trans paired nicking strategy achieves multiplexed, single-step,
gene targeting, and yields higher frequencies of accurately edited cells when compared to the
standard double-stranded DNA break-dependent approach.
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Programmable nucleases, and in particular RNA-guidednucleases (RGNs), are rendering genome editing applicableto numerous basic and applied research settings1–3. RGNs
are ribonucleoprotein complexes formed by a guide RNA (gRNA)
and a Cas9 protein with two nuclease domains, i.e., HNH and
RuvC. RGNs cleave DNA complementary to the 5′ end of the
gRNA when a contiguous protospacer adjacent motif (PAM) is
present3. The fact that target DNA cutting is ultimately dictated
by simple RNA-DNA hybridization rules confers versatility to
RGN technologies1–3. A major drawback of conventional DNA
editing stems, however, from the fact that double-stranded DNA
break (DSB) repair in mammalian cells often takes place via
mutagenic non-homologous end joining (NHEJ) instead of
accurate homologous recombination (HR)4. As a result, allelic
and non-allelic mutations, loss-of-heterozygosity, translocations,
and other unwarranted genetic changes caused by on-target and
off-target DSBs, are frequent5. Moreover, NHEJ also contributes
to random and imprecise chromosomal insertion of the donor
DNA1, 6. As a whole, these unpredictable genome-modifying
events complicate the interpretation of experimental results and
reduce the safety profile of candidate genetic therapies. Despite
this, in certain experimental settings, such as those amenable to
cell isolation and screening, homology-independent chromoso-
mal DNA insertion is a valuable genetic modification strategy
owing to its efficiency and applicability to non-dividing target
cells7–9.
Following from the above, developing new genome-editing
principles that favor not only efficient but also precise homology-
directed gene targeting in detriment of mutagenic NHEJ are in
demand. Indeed, emergent genome-editing research lines involve
testing small RNAs, drugs, or viral proteins that steer DSB repair
towards the HR pathway by inhibiting the competing NHEJ10–12.
Parallel research lines exploit sequence-specific and strand-
specific programmable nucleases (“nickases”)13–17 for generat-
ing single-stranded DNA breaks (SSBs), or nicks, which are non-
canonical NHEJ substrates4. Besides bypassing DSB formation,
“nickases” do not alter the regular cellular metabolism as small
RNAs, drugs and viral proteins do. However, genome editing
based on “nickases” is inefficient13, 15–17. In fact, the investigation
of site-specific SSBs as triggers for homology-directed targeting of
large DNA segments (e.g., entire transcriptional units) has not
been explored.
Here, we investigate the feasibility of exploiting nicking RGNs
containing the RuvC Cas9 mutant Asp10Ala (Cas9D10A) or the
HNH Cas9 mutant His840Ala (Cas9H840A) to trigger genome
editing via the simultaneous formation of SSBs at endogenous
and exogenous DNA. We report that this strategy based on
coordinated in trans paired nicking can improve the three
main parameters of DNA editing, i.e., efficiency, specificity, and
fidelity1, 2 and achieves multiplexing homology-directed DNA
addition of large genetic payloads.
Results
Mutagenesis caused by cleaving Cas9 vs. nicking Cas9. We
started by confirming that unwarranted, potentially adverse,
genome-modifying events (i.e., target allele mutagenesis and
chromosomal translocations)1 do occur more frequently in cells
exposed to cleaving Cas9 than in those subjected to nicking Cas9
proteins. Firstly, we assessed the mutation rates resulting from
RGN complexes consisting of cleaving (i.e., Cas9:gRNAX) or
nicking Cas9 nucleases (i.e., Cas9D10A:gRNAX or Cas9H840A:
gRNAX), where “X” symbolizes the target locus. The Cas9D10A
and Cas9H840A proteins differ from wild-type Cas9 in that they
have amino-acid substitutions disrupting the catalytic centers of
their RuvC and HNH nuclease domains, respectively. As a result,
RGN complexes with Cas9D10A and Cas9H840A induce sequence-
specific and strand-specific breaks on opposite DNA chains,
namely, on the chain complementary and non-complementary to
the gRNA, respectively. The AAVS1 locus at 19q13.42 was
selected for these experiments owing to its frequent use as a “safe
harbor” for the targeted chromosomal insertion of exogenous
DNA18. This assessment is based on a series of studies showing
that AAVS1 integrants are neither disturbed by, nor disturb the
surrounding genomic environment, providing for long-term and
stable transgene expression in different cell types18. A target site
genotyping assay in human embryonic kidney 293 T cells showed
that Cas9:gRNAS1 complexes targeting the AAVS1 locus readily
yielded substantially higher levels of DSBs than their Cas9D10A:
gRNAS1 counterparts (Supplementary Fig. 1a). To augment the
stringency of the genotyping assay, we next carried out
dose–response experiments in human cervix carcinoma HeLa
cells using increasing amounts of adenoviral vectors encoding
either Cas9 or Cas9D10A, each mixed with a fixed amount of an
adenoviral vector expressing a gRNA addressing each Cas9 pro-
tein to AAVS1. A direct relationship between the detection of
small insertions and deletions (indels) and nuclease concentra-
tions could be readily established after Cas9:gRNAS1 delivery,
whereas this was much less so upon Cas9D10A:gRNAS1 transfer
(Supplementary Fig. 1b). These data directly correlated with the
much higher frequencies of indel-derived EGFP disruption in
EGFP+ H27 reporter cells triggered by cleaving Cas9:gRNAGFP2
when compared to those induced by nicking Cas9D10A:gRNAGFP2
or by Cas9H840A:gRNAGFP2 complexes (Supplementary Fig. 1c).
Secondly, we setup a PCR assay to compare the assembly of
chromosomal translocations caused by the formation of DSBs vs.
SSBs at two distinct loci. To this end, HeLa cells were transfected
with plasmids coding for cleaving or nicking RGNs targeting
DMD and AAVS1 sequences. Amplicons diagnostic for transloca-
tion events between DMD and AAVS1 were exclusively detected
in cells exposed to the cleaving RGNs (Supplementary Fig. 1d).
Sanger sequencing of individual amplicons established their
origin at t(X;19)(p21;q13) (Supplementary Fig. 1e). Taken
together, these experiments formally demonstrate that unwar-
ranted, potentially adverse, genome-modifying events occur more
frequently in cells receiving RGNs containing cleaving Cas9 than
in those harboring nicking Cas9D10A.
In trans paired nicking yields seamless DMD gene targeting.
Next, we sought to investigate homology-directed gene targeting
based on inducing DSBs vs. SSBs not only at acceptor chromo-
somal sequences but also at donor DNA templates. The DMD
gene at Xp21.2 was chosen as target locus. By spanning over 2.4
Mb, DMD is the largest human protein-coding gene known. Of
note, defective DMD alleles cause Duchenne muscular dystrophy
(DMD), a progressive lethal neuromuscular disease affecting ∼1
in 3500–5000 boys19, 20. For these experiments, we generated
plasmid pgRNADMD, to address Cas9 proteins to DMD intron 43,
and EGFP-encoding constructs pDonorDMD and pDonorDMD.TS
to serve as exogenous HR substrates (Fig. 1a). Construct
pDonorDMD.TS differs from pDonorDMD in that it has a target
site (TS) for gRNADMD next to its targeting module (Fig. 1a).
Importantly, all transgene-containing donors used in the present
study have autonomous transcription units, which in contrast to
splice acceptor-containing gene trapping constructions, avoid
biased selection of on-target integrants21. Genome-editing
experiments were initiated by exposing HeLa cells to
pDonorDMD and cleaving Cas9:gRNADMD complexes (standard
setting) or to pDonorDMD.TS and nicking Cas9D10A:gRNADMD
complexes (in trans paired nicking; Nick2). After eliminating
episomal DNA by sub-culturing, genetically modified cells were
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quantified through flow cytometry. This analysis revealed that the
in trans paired nicking strategy led to significantly higher per-
centages of genetically modified cells when compared to those
obtained through the standard approach (Fig. 1b). Similar results
were obtained by using donor constructs whose DMD-targeting
modules were flanked by the gRNADMD TS in a direct or inverted
repeat orientation (Supplementary Fig. 2). These data are con-
sistent with earlier theoretical models and more recent experi-
mental systems indicating a role for nicked HR partners as
recombination-initiating substrates22, 23. Of note, although at this
target sequence paired DSB formation (in trans paired breaking;
DSB2) yielded the highest frequencies of EGFP+ cells, the
resulting free-ended HR substrates are prone to aberrant con-
catemer assembly (see below). Indeed, it has been previously
shown that the DSB2 strategy results in higher frequencies of
random chromosomal insertions through illegitimate recombi-
nation processes when compared to those obtained by the stan-
dard DSB-dependent gene targeting approach6. Conversely,
consistent with previous studies13, 15–17, generating SSBs exclu-
sively at chromosomal DNA yielded the lowest frequencies of
stably transfected cells.
Subsequently, we compared in trans paired nicking with
standard gene targeting in terms of their relative specificities
and fidelities. The specificity is ascertained by detecting
donor sequences at the target site; the fidelity is established
by demonstrating that telomere-sided and centromere-sided
junctions between donor and target DNA are formed through
error-free HR (jT+ and jC+, respectively). Randomly selected
EGFP+ HeLa clones (n= 98) were screened via PCR assays
targeting both junctions (Fig. 1c and Supplementary Fig. 3). In
the set of clones modified through the delivery of pDonorDMD,
pCas9 and pgRNADMD (n= 51), the DMD-targeted fraction was
27.5% with 21.6% of these integrants being accurately targeted
(jT+/jC+). Notably, in the set of clones modified via the transfer
of pDonorDMD.TS, pCas9D10A and pgRNADMD (n= 47), these
fractions were 93.6% and 42.6%, respectively (Fig. 1c). We
conclude that, when compared to conventional DSB-induced
gene targeting, in trans paired nicking was more efficient, specific,
and accurate at the DMD locus.
In trans paired nicking yields seamless AAVS1 gene targeting.
We next examined the performance of in trans paired nicking
and standard gene targeting at AAVS1 (Fig. 2a). As aforemen-
tioned, this locus is commonly used as a “safe harbor” for the
chromosomal insertion of exogenous DNA in human cells18.
These experiments were initiated by transfecting HeLa and 293
T cells with pDonor.ES1 or pDonor.ES1.TS each mixed with
plasmids encoding either Cas9:gRNAS1 or Cas9D10A:gRNAS1
(Fig. 2a). The pDonor.ES1.TS construct has its targeting module
flanked by two gRNAS1 TS (Fig. 2a). The rationale for this donor
design was provided by the experiments showing that such
arrangement yields significantly higher frequencies of stably
transfected cells when compared to isogenic templates containing
a single gRNAS1 TS (Supplementary Fig. 4). In agreement with
the DMD-targeting experiments, when compared to experiments
involving single DSBs (standard setting) or single SSBs, in trans
paired nicking of AAVS1 and pDonor.ES1.TS led to significantly
higher percentages of genetically modified cells (Fig. 2b). Similar
results were gathered by using different gRNA and donor DNA
reagents or the alternative nicking Cas9H840A variant whose
inactivated HNH domain assures that SSBs occur at the DNA
chain opposite to that hydrolyzed by its RuvC-disabled Cas9D10A
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Fig. 1 Homology-directed DMD-targeting using standard and in trans paired nicking strategies. a Schematics of standard and in trans paired nicking (Nick2)
procedures. The former involve DSB formation only at the target sequence; the latter comprise SSB formation at target plus donor sequences. pDonorDMD
and pDonorDMD.TS have their transgenes flanked by sequences identical to those framing the gRNADMD target site (TS). Open and solid magenta
arrowheads, position of the phosphodiester bond cleavage induced by Cas9’s RuvC and HNH nuclease domains, respectively. Solid arrowhead, position of
the SSB induced by Cas9D10A. The modified pDonorDMD.TS differs from pDonorDMD in that it has the gRNADMD TS next to its targeting module. The
transgene is formed by human PGK1 promoter, EGFP ORF, and bovine GH1 polyadenylation signal sequences. Cas9:gRNADMD and Cas9D10A:gRNADMD are
cleaving and nicking RGN complexes, respectively. PAM protospacer adjacent motif. An integrant generated by HR events at both ends of the targeting
module is depicted. The amplicons specific for telomere-sided and centromere-sided transgenic-DMD junctions (jT and jC, respectively), are equally
shown. Horizontal arrowheads, primers. b Quantification of stable transfection levels by flow cytometry. Flow cytometry of long-term HeLa cell cultures
initially exposed to the indicated plasmids. The bars correspond to mean± s.d. of three independent biological replicates done on different days.
**P= 0.006 (two-tailed t-test). c Cumulative molecular characterization of integrants generated by the conventional vs. the in trans paired nicking
strategies. The frequencies of clones with random insertions (jT−/jC−), HR-derived telomeric junctions (jT+/jC−), HR-derived centromeric junctions
(jT−/jC+) and HR-derived telomeric and centromeric junctions (jT+/jC+) are plotted. The corresponding PCR screening data are presented in
Supplementary Fig. 3
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diagnostic for HR-derived integrants were readily retrieved not
only from cells subjected to inaccurate DNA editing by paired
DSB formation but also from cells exposed to the accurate in
trans paired nicking procedure (Fig. 2c). Indeed, in striking
contrast to inducing in trans paired DSBs (DSB2), generating in
trans paired SSBs (Nick2), did not result in the assembly of
disruptive donor DNA concatemers (Fig. 2c), presumably emer-
ging through ligation of free-ended termini generated in cellula
by Cas9:gRNAS16. Finally, we probed an alternative in trans
paired nicking gene targeting strategy in which two different
gRNAs generate tandem SSBs within the interacting homologous
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transfection levels that were within the range of those achieved by
using the standard, DSB-dependent, gene targeting procedure
(Supplementary Fig. 6).
To gauge the specificity and fidelity resulting from in trans
paired nicking vs. standard gene targeting at AAVS1, randomly
selected EGFP+ clones (n= 275) were isolated from HeLa and
293 T cell populations and were screened through junction PCR
(Fig. 2d and Supplementary Fig. 7). We observed that 63.9% and
66.7% of the HeLa and 293 T cells exposed to the standard setting
underwent accurate homology-directed gene targeting (jT+/jC+),
respectively (Fig. 2d). In the remaining clones, illegitimate
recombination led instead to off-target integrants (jT−/jC−) and
to on-target integrants lacking HR-derived junctions either from
the centromeric or telomeric side (jT+/jC− or jT−/jC+,
respectively). Remarkably, the fraction of properly targeted HeLa
and 293 T cells subjected to in trans paired nicking was as high as
97.2 and 100%, respectively (Fig. 2d). Finally, Sanger sequencing
established that precisely targeted integrants resulting from in
trans paired nicking and conventional gene targeting were
undistinguishable (Supplementary Fig. 8).
To complement the previous gene targeting experiments
involving sizable and transcriptionally active donor constructs,
we next asked whether short, transcriptionally inert donor
constructs, can equally serve as in trans paired nicking substrates.
To this end, AAVS1-targeting plasmids pS.DonorS1 and pS.
DonorS1.TS, resistant and susceptible to RGNs, respectively
(Fig. 2e, left panel), were transfected into human cells together
with constructs expressing Cas9:gRNAS1 or Cas9D10A:gRNAS1
(Fig. 2e, middle panel). HR engaging pS.DonorS1 or
pS.DonorS1.TS sequences should result in the targeted chromo-
somal insertion of 18-bp DNA fragments incorporating restric-
tion enzyme polymorphisms (Fig. 2e, middle panel). Detection of
these genome-editing events by restriction enzyme fragment
length analysis (RFLA) revealed that in trans paired nicking is
compatible with the use of short, transcriptionally inert, donor
DNA templates (Fig. 2e, right panel).
Paired RGNs inducing offset nicks on opposite chromosomal
DNA strands ensure that DSBs are mostly restricted to their
bipartite target sequences owing to the coordinated and local
formation of SSBs on both polynucleotide chains24, 25. The
resulting gains in DNA cutting specificity render this dual RGN
approach appealing, hereafter named in cis paired nicking for the
sake of consistency. Hence, albeit dependent on two gRNAs and
on the generation of mutagenic DSBs, we sought nonetheless to
compare in cis with in trans paired nicking as stimuli for site-
specific chromosomal DNA insertion (knock-in). Therefore, in
addition to the four experimental conditions tested before
(Fig. 2b), in these new experiments, we transfected human cells
with pDonorS1 and pCAG.Cas9D10A mixed with constructs
expressing two different AAVS1-specific gRNA pairs (i.e.,
gRNAS1/gRNAS1.2 or gRNAS1/gRNAS1.3). Consistent with the
previous data (Fig. 2b), the in trans paired nicking setup yielded
the highest frequencies of genetically modified cells. The in cis
paired nicking strategy led, in turn, to frequencies of genetically
modified cells that were in the range of those obtained by
inducing DSBs or SSBs exclusively at the target site (Supplemen-
tary Fig. 9).
In trans paired nicking in pluripotent stem cells. Despite their
patent scientific and biomedical importance, genetic manipula-
tion of human pluripotent stem cells (PSCs) remains limited by
the typically low efficiency, specificity, and accuracy of homology-
directed gene targeting, even when using programmable nucleases
(see e.g., ref. 21). Therefore, we investigated the performance of in
trans paired nicking in human induced PSCs (iPSCs; Supple-
mentary Fig. 10) and human embryonic stem cells (ESCs)26. In
addition to pDonorS1 and pDonorS1.TS (Supplementary Fig. 4a),
we included in these experiments, pDonor.EPS1 and pDonor.
EPS1.TS encoding PuroR.T2A.EGFP instead of EGFP. The data
generated with these new HR substrates in HeLa cells (Supple-
mentary Fig. 11) were similar to those of previous experiments
showing the superiority of in trans paired nicking over standard
gene targeting in achieving efficient cell engineering at AAVS1
(Fig. 2b and Supplementary Figs. 4b–6 and 9). Importantly, this
superiority was equally established in iPSCs and ESCs by using
dual-color flow cytometry and colony-formation assays involving
the detection of EGFP+/TRA-1-81+ cells (Fig. 3a, b) and
puromycin-resistant colonies stained for alkaline phosphatase,
respectively (Fig. 3c). In addition, when compared to in trans
paired nicking, DSB-triggered AAVS1 targeting induced higher
frequencies of apoptotic Annexin V+ cells in ESC cultures
(Supplementary Fig. 12). These results are consistent with the
well-established sensitivity of PSCs to DSBs27.
To determine the precision of genome editing in iPSCs
subjected to in trans paired nicking vs. standard genome-
editing protocols, puromycin-resistant clones (n= 80) were
screened with a PCR assay specific for HR-derived junctions
(Fig. 3d and Supplementary Fig. 13). The gene targeting
specificity in iPSCs exposed to standard and in trans paired
Fig. 2 Homology-directed AAVS1 targeting using standard and in trans paired nicking strategies. a Diagram of standard and in trans paired nicking (Nick2)
procedures. The former involve DSB formation only at the target sequence; the latter comprise SSB formation at target plus donor sequences. pDonorS1 and
pDonorS1.TS have their transgenes framed by sequences homologous to AAVS1. pDonorS1.TS differs from pDonorS1 in that it has the gRNAS1 target site (TS)
bracketing its EGFP-encoding targeting module. Cas9:gRNAS1 and Cas9D10A:gRNAS1 are cleaving and nicking RGNs, respectively. Open and solid magenta
arrowheads, position of the phosphodiester bond cleavage induced by Cas9’s RuvC and HNH nuclease domains, respectively. Solid arrowhead, position of
the SSB induced by Cas9D10A. Amplicons diagnostic for telomere-sided and centromere-sided transgenic-AAVS1 junctions (jT and jC, respectively), are
depicted. b Quantification of stably transfected cells. Flow cytometry of long-term HeLa and 293 T cell cultures initially transfected with the indicated
plasmids. The bars correspond to mean± s.d. of six biological replicates from two independent experiments (three biological replicates per experiment).
****P< 0.0001 (two-tailed t-tests). c Probing for wanted (gene targeting) and unwanted (concatemerization) genome-modifying events. Amplicons
diagnostic for gene targeting (jC) and head-to-tail concatemers (jH-T) in 293 T cell populations transfected with the indicated constructs are presented.
This assay was also run on EGFP-sorted cells (post-sorted). EGFP served as an internal control template. d Cumulative molecular characterization of
integrants generated by the conventional and in trans paired nicking strategies. The frequencies of clones with random insertions (jT−/jC−), HR-derived
telomeric junctions (jT+/jC−), HR-derived centromeric junctions (jT−/jC+) and HR-derived telomeric and centromeric junctions (jT+/jC+) are plotted. The
respective PCR screening data are presented in Supplementary Fig. 7. e Homology-directed AAVS1 editing after inducing DSBs or SSBs. pS.DonorS1 and pS.
DonorS1.TS have a restriction-fragment length polymorphism (RFLP) flanked by 300-bp AAVS1 sequences (“arms”). pDonorS1.TS has the gRNAS1 TS flanking
its targeting module (orange boxes). RFLA restriction-fragment length analysis; half arrows primers; PAM boxed sequence. RFLA products diagnostic for
unedited and HR-edited AAVS1 alleles retrieved from HeLa cells transfected with the indicated plasmid combinations are identified by open and closed
arrowheads, respectively
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nicking procedures was 65 and 93%, respectively (Fig. 3d and
Supplementary Fig. 13). Contributing to the difficulty in isolating
iPSC lines that undergo seamless genome editing is the fact that a
sizable fraction of cells, in addition to the intended genetic
modification at one of the target alleles, harbor mutations at the
other allele28. These mutations correspond to unpredictable indel
footprints created after NHEJ-mediated repair of targeted DSBs28.
Hence, to further characterize the genetically modified iPSCs,
nucleotide sequence analysis of target DNA was performed in
individual iPSC clones subjected to standard and in trans
paired nicking protocols. This analysis revealed the presence of
a range of indel footprints exclusively in the iPSC lines generated
by standard gene targeting (Fig. 3f). Indeed, the AAVS1 target site
remained pristine in all of the randomly selected iPSC lines
obtained after applying the in trans paired nicking protocols
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(Supplementary Fig. 1) and the fact that, in contrast to DSBs,
SSBs are not canonical substrates for NHEJ.
Finally, iPSC lines genetically engineered through standard and
in trans paired nicking remained pluripotent (Fig. 3e and
Supplementary Fig. 14). We conclude that, instead of generating
DSBs, targeted DNA integration at the AAVS1 “safe harbor” in
different cell types is best achieved via coordinated RGN-induced
paired nicking of donor and acceptor DNA.
Multiplexing gene targeting by in trans paired nicking. To
confirm that AAVS1-targeting donor DNA subjected to RGN
nicking is a superior substrate for site-specific chromosomal DNA
insertion, we setup competition experiments involving the co-
targeting of two donors each encoding a different reporter, i.e.,
EGFP or mTurquoise2 (Fig. 4a). For these experiments, one of the
two donors contained TS sequences, whereas the other did not
(Fig. 4a). Flow cytometry showed that pDonorS1.TS and pDonor.
TurqS1.TS subjected to RGN-induced nicking led to 15-fold
and 23-fold higher frequencies of genetically modified cells,
respectively, when compared to their competitor, RGN-resistant,
donor counterparts pDonorS1 and pDonor.TurqS1 (Fig. 4b, c).
Consistent with these results, homology-directed gene targeting
in cells containing both RGN-resistant and RGN-susceptible
donors involved primarily the latter substrates, independently of
the product that they encoded (Fig. 4d).
Hitherto, multiplexing genome editing has primarily entailed
NHEJ-based manipulations such as those involving RGN pairs
for knocking-out two genes simultaneously or for creating
chromosomal deletions1. Such approaches are, however, not
applicable for the targeted addition of new genetic information.
For this purpose, multiplexing homology-directed DNA insertion
based on different donor constructs can, in principle, be used
instead. Unfortunately, HR-dependent chromosomal knock-in of
two different donors in individual cells is a very rare event.
Moreover, in addition to generating high frequencies of indel
footprints, the necessary programmable nuclease pairs can induce
loss-of-heterozygosity and/or translocations (Supplementary
Fig. 1). Therefore, engineering cells with exogenous DNA inserted
at two different loci or at two alleles of a single locus (bi-allelic
targeting) is normally a complex and time-consuming procedure.
Indeed, these procedures include constructing donors with
positive/negative selection markers for isolating and screening
the few cells that undergo seamless gene targeting, often followed
by marker removal. This lengthy process is subsequently repeated
on the selected cell clone(s) using, this time, a second donor
construct.
We thus sought to capitalize on the higher efficiency, specificity
and accuracy of in trans paired nicking over the conventional
DSB-dependent strategy at AAVS1, for testing one-step
co-targeting of different alleles. These multiplexing knock-in
experiments were initiated by exposing HeLa cells to
pDonorS1.TS, pDonor.TurqS1.TS, and nicking Cas9D10A:gRNAS1
(Fig. 5a). Controls consisted of treating HeLa cells with pDonorS1,
pDonor.TurqS1, and cleaving Cas9:gRNAS1 (Fig. 5a). Remarkably,
in comparison with the control setting, the multiplexing approach
based on in trans paired nicking yielded one order of magnitude
higher amounts of doubly-labeled EGFP+/mTurquoise2+ cells as
measured by flow cytometry (Fig. 5b, c). These results directly
correlated with the detection of HR-specific amplicons in parallel
genomic DNA samples (Fig. 5d). After flow cytometry-assisted
sorting of these EGFP+/mTurquoise2+ cells (Supplementary
Fig. 15), single-cell clonal analysis (n= 35) revealed that 89% of
them underwent AAVS1-targeting events, of which 94% were bi-
allelic events involving both donor DNA templates (Supplemen-
tary Fig. 16a, b). An independent assay based on Southern blot
analysis confirmed co-targeting of both expression units in
individual cells without evidence for random chromosomal DNA
insertion (Supplementary Fig. 16a, c). Taken together, these data
show that simultaneous in trans paired nicking of independent
donor substrates can provide for a simpler and faster strategy for
achieving, in a seamless manner, multiplexed addition of foreign
DNA into the genome of human cells.
In trans paired nicking yields seamless gene editing at CCR5.
The product of the C–C motif chemokine receptor 5 gene CCR5,
located at 3p21.31, serves as an HIV-1 co-receptor on macro-
phages and T cells29. Crucially, individuals homozygous for a 32-
bp deletion disrupting CCR5 function (CCR5Δ32) are healthy and
refractory to R5-tropic HIV-1 infection29. Hence, this locus is an
appealing target for testing HIV therapies based on viral co-
receptor knockout and site-specific “stacking” of restriction factor
genes29. In addition, similarly to AAVS1, CCR5 is frequently used
as a generic “safe harbor” for the targeted chromosomal insertion
of foreign DNA in human cells18. Thus, we next sought to
compare DSB-dependent vs. SSB-dependent genome-editing
approaches at CCR5 after delivering RGNs together with CCR5-
targeting constructs pS.DonorR5 or pS.DonorR5.TS marked with
restriction enzyme polymorphisms (Fig. 6a). In these experi-
ments, RFLA and mismatch-sensing T7 endonuclease I (T7EI)
genotyping assays were deployed for assessing genomic changes
through HR and/or NHEJ (Fig. 6b). Human cells treated with in
trans paired nicking (Nick2) and in trans paired breaking (DSB2)
protocols readily yielded noticeable HR-specific RFLA products
(Fig. 6c, top panel). A preponderance of T7EI-digested products,
diagnostic for the cumulative build-up of NHEJ and HR events,
was detected in cells subjected to DSB-inducing protocols (Fig. 6c,
Fig. 3 Comparing RGN-induced gene targeting based on standard and in trans paired nicking in human PSCs. a Quantification of genetically modified PSCs
by flow cytometry. Cultures of iPSCs (A, B, and E) and ESCs (C and D) were exposed to AAVS1-specific cleaving Cas9:gRNAS1 (standard) or nicking
Cas9D10A:gRNAS1 (Nick2) complexes mixed with RGN-resistant or RGN-susceptible donor constructs, respectively, encoding either EGFP or PuroR.T2A.
EGFP. The frequencies of gene-modified PSCs were determined by flow cytometric quantification of EGFP+ and TRA-1-81+ dually labeled cells.
b Representative flow cytometry dot plots corresponding to RGN-induced gene targeting experiments in PSCs. c Detection of gene-modified PSCs by
colony-formation assays. ESCs (top) and iPSCs (bottom) were co-transfected with the indicated plasmids. After puromycin selection, alkaline phosphatase
staining identified genetically modified PSC colonies. d RGN-induced gene targeting frequencies at AAVS1 in iPSCs. Junction PCR analyses of puromycin-
resistant colonies from iPSC cultures initially co-transfected with pDonor.EPS1 and pCas9.gRNAS1 (standard) or with pDonor.EPS1.TS and pCas9D10A.gRNAS1
(Nick2). The respective PCR screening data are presented in Supplementary Fig. 13. e Differentiation potential of gene-edited PSCs. ESC and iPSC lines
were targeted at AAVS1 by in trans paired nicking. Cell types characteristic of ectoderm, endoderm, and mesoderm were identified by confocal
immunofluorescence microscopy for TUBB3, AFP, and CD31, respectively. f Characterization of indel footprints in iPSCs subjected to standard vs. in trans
paired nicking. Nucleotide sequencing of AAVS1 target alleles in randomly selected iPSC clones (n= 68) genetically modified by DSB-dependent and in
trans paired nicking methodologies (Standard and Nick2, respectively). Indel footprints were exclusively identified in iPSCs subjected to the standard gene
targeting approach (15/28). The gRNAS1 target site is indicated underneath the sequence reads. Open box PAM; vertical dashed line position of expected
RGN-induced phosphodiester bond cleavage; Ctrl reference wild-type nucleotide sequence from unedited cells
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Fig. 4 Competition for gene targeting between donor DNA resistant and sensitive to RGN-induced nicking. a Schematics of the experimental design. HeLa
cells were co-transfected with the indicated donor templates together with plasmids encoding nicking Cas9D10A:gRNAS1. b Quantification of stably
transfected cell populations. The frequencies of genetically modified cells were determined at 27 days post-transfection by EGFP-directed and
mTurquoise2-directed flow cytometry. The ratios between the frequencies of the various gene-modified subpopulations are presented. c Flow cytometry
dot plots corresponding to the end-point of the experiments. Mock-transfected cultures served to set the thresholds for background fluorescence (negative
control). d Gene targeting in cells containing donor DNA resistant and susceptible to RGN nicking. Amplicons diagnostic for homology-directed gene
targeting involving EGFP-encoding and mTurquoise2-encoding donor templates are indicated. HPRT1 provided for an internal control target sequence
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Fig. 5 Multiplexing homology-directed DNA addition. a Diagram of the experimental design. HeLa cells were co-transfected with the indicated donor
constructs together with plasmids encoding either cleaving Cas9:gRNAS1 or nicking Cas9D10A:gRNAS1 complexes. b Quantification of stably transfected cell
populations. The frequencies of genetically modified cells were determined at 27 days post-transfection by EGFP-directed and mTurquoise2-directed flow
cytometry. The ratios between the frequencies of the double-positive cell populations generated by standard and in trans paired nicking multiplexing, are
presented. Numerals between brackets correspond to the fraction of each gene-modified subpopulation. c Flow cytometry dot plots corresponding to the
end-point of the experiments. Parallel cultures transfected with a single donor construct mixed with plasmids expressing Cas9:gRNAS1 or Cas9D10A:gRNAS1
served as controls for setting the thresholds for EGFP and mTurquoise2 detection. d Gene co-targeting in cells containing a mixture of two donors resistant
or susceptible to RGN nicking. PCR products specific for homology-directed gene targeting involving EGFP-encoding and mTurquoise2-encoding donor
templates are indicated. HPRT1 provided for an internal control target sequence
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middle panel). This outcome is consistent with the prevalence of
the former over the latter pathway during the repair of DSBs in
mammalian cells4. Of note, T7EI-digested products correspond-
ing to the in trans paired nicking protocol should mostly repre-
sent HR events as nicking exclusively at CCR5 (single nick) led to
the lowest signals in both genotyping assays (Fig. 6c). In a follow-
up experiment, in addition to the four experimental conditions
tested earlier (Fig. 6c), we included in cis paired nicking at CCR5
by transfecting HeLa cells with pS.DonorR5 and pCas9D10A mixed
with plasmids expressing the gRNA pair gRNAR5.1/gRNAR5.2. In
agreement with the previous data (Fig. 2c), in trans paired nicking
induced robust accumulation of HR-specific RFLA products.
Importantly, cells exposed to DSB-inducing single and dual RGN
















































































































































































































































: TargetDSB SSB DSB –
pS.DonorR5
RFLP














































































































Donor : DSB 





















ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00687-1
10 NATURE COMMUNICATIONS | 8:  657 |DOI: 10.1038/s41467-017-00687-1 |www.nature.com/naturecommunications
when compared to those subjected to the SSB-inducing Cas9D10A:
gRNAR5.1 complex (Fig. 6e). These results confirm that in trans
paired nicking can achieve programmable nuclease-assisted gen-
ome editing without concomitantly introducing a high mutagenic
load into target cell populations.
Discussion
In this study, we have demonstrated that in trans paired nicking
based on combining RGN “nickases” with RGN-targetable donors
can trigger robust and seamless chromosomal insertion of small
and large genetic payloads into specific genomic sequences in
human cells without the catalytic induction of DSBs. We spec-
ulate that the rate-limiting HR steps of single-stranded DNA
invasion, donor–acceptor synaptic formation and heteroduplex
expansion are, to a great extent, overcome by coordinated pre-
sentation of 3′ termini on both interacting partners after in trans
paired nicking. These events are shared by recent working models
invoking SSBs as recombination-initiating substrates30. In addi-
tion, recent experiments indicate the involvement of distinct
factors underlying canonical and SSB-induced HR pathways. For
instance, recombination between donor DNA and a nicked target
sequence can proceed through RAD51/BRAC2-independent
pathways30. In this regard, the versatility of RGNs for inducing
nicks at different positions and strands of HR templates, might
constitute a valuable experimental system to dissect SSB-
dependent HR pathways and, possibly, further improve genome
editing based on in trans paired nicking concepts.
Importantly, we also showed that avoiding the use of DSB-
inducing nucleases confers a low mutagenic load to this new
genome-editing paradigm. Hence, our research complements and
joins those of others on devising high-efficiency genome-editing
strategies based on RGN “nickases”31, 32. In particular, a recent
study has demonstrated that fusing cytidine deaminase and uracil
DNA glycosylase activities to Cas9D10A results in a large “base
editor” capable of inducing C→T substitutions within a ∼5 nt
target window31. Another recent study revealed that cleaving and
nicking RGNs expose a DNA flap accessible to single-stranded
oligodeoxyribonucleotide (ssODN) annealing32. On the basis of
this information, rationally designed ssODNs and RGN “nicka-
ses” were combined and shown to yield homology-directed gene
repair in ∼10% of treated 293 reporter cells32. An intrinsic lim-
itation of these approaches is, however, their unsuitability for
effecting extensive genetic changes. Moreover, the fidelity of “base
editors” depends on the absence of extra cytidines within the ∼5
nt “activity window”, while that of coupling RGN “nickases” to
ssODNs relies on the lack of adventitious mutations created
during synthesis and processing of ssODNs in vitro and in cellula,
respectively33.
The high specificity and accuracy conferred by in trans paired
nicking genome editing coupled to its low mutagenic load should
be particularly useful in instances in which the precise genetic
manipulation of target cell populations is paramount. Examples
include the modeling or the repairing of disease traits in stem/
progenitor cells and the unbiased genetic screening of cellular
phenotypes based on HR-mediated chromosomal insertion of
donor DNA libraries34. Of note, however, regardless of the DNA
targeting specificity and fidelity attained by a particular genome-
editing procedure, there is always the risk for uncontrollable
random chromosomal insertion of the exogenous DNA. Clearly,
these unwanted events can take place in cells that lack or harbor
the intended genetic modification.
We have confirmed that nicking RGNs are significantly less
mutagenic than their cleaving counterparts at on-target sequences
(Supplementary Fig. 1). Moreover, experiments done by others
have demonstrated that, when compared to cleaving RGNs,
nicking RGNs are also significantly less mutagenic at off-target
sites25. However, regarding the use of “nickases” specifically, one
should caution that SSBs can still trigger some mutagenic events
if, for instance, after hitting such lesions, an advancing replication
fork collapses resulting in DSB formation5. These outcomes will
be most problematic at off-target sites. In this regard, sensitive
and unbiased assays allowing the genome-wide detection of nick-
induced mutagenesis will be instrumental in the future for
determining the mutagenic load of gene-editing protocols based
on programmable “nickases”. Equally related with off-target
activities, programmable “nickases” with improved specificities
are in demand. Possible candidates include RGN “nickases” built
on recently described high-specificity Cas9 scaffolds such as Sp
Cas9-HF135 and eSpCas9(1.1)36. We anticipate that the simple
and versatile in trans paired nicking procedure will be compatible
with these latest generation tools and, possibly, with other fast-
emerging DNA targeting systems.
Concluding, the performance of genome editing depends on its
overall efficiency, specificity and fidelity1. In this work, we have
shown that testing combinatorial interactions between different
types of nucleases and foreign DNA structures, can improve these
crucial parameters, expanding the options for high-fidelity genetic
manipulation of mammalian cells.
Methods
Cells. Human cervix carcinoma HeLa cells (American Type Culture Collection)
and its EGFP expressing single cell-derived clone H2737 were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; ThermoFisher Scientific) containing
5% fetal bovine serum (FBS; ThermoFisher Scientific). Human embryonic kidney
(HEK) 293 T cells (American Type Culture Collection) were maintained in DMEM
supplemented with 10% FBS. These cells were kept at 37 °C in an humidified-air
10% CO2 atmosphere. The human embryonic stem cell (ESC) line H1 (ref. 26;
WiCell Research Institute) and the induced pluripotent stem cell (iPSC) lines
Fig. 6 Homology-directed CCR5 editing after DSB vs. SSB generation. a Diagram of the different DSB-dependent and SSB-dependent genome-editing
strategies. pS.DonorR5 and pS.DonorR5.TS have a restriction-fragment length polymorphism (RFLP) flanked by 400-bp CCR5 sequences (“arms”). pS.
DonorR5.TS has the gRNAR5.1 target site (TS) bracketing its targeting module (orange boxes). Combining Cas9D10A:gRNAR5.2 and Cas9D10A:gRNAR5.1
complexes generates a targeted DSB by nicking on opposite DNA strands (in cis paired nicking strategy). PAMs boxed sequences; magenta arrowheads,
positions of the DSBs and SSBs generated by Cas9 and Cas9D10A, respectively. b Schematics of the CCR5 genotyping assays. DNA products diagnostic for
unedited, edited, and mutagenized CCR5 alleles are indicated. RFLA restriction-fragment length analysis; T7EI mismatch-sensing T7 endonucleases I assay;
half arrows, primers c CCR5 genotyping assays. Genotyping of CCR5 sequences by RFLA and T7EI assays in HeLa cells transfected with the indicated
plasmid sets. RFLA products specific for unedited and HR-edited CCR5 alleles are identified by open and closed arrowheads, respectively; T7EI digestion
products diagnostic for genetic changes induced at CCR5 by HR and NHEJ are equally indicated. The genomic DNA analyses were performed at 3 days
post-transfection. d Comparing genome-editing strategies based on single vs. dual RGNs. HeLa cells were co-transfected with the indicated plasmids and
3 days later RFLA was performed on their genomic DNA. Open and solid arrowheads point to unedited and HR-edited CCR5 sequences, respectively.
e Comparing CCR5 mutagenesis in cells exposed to RGNs inducing DSBs vs. SSBs. HeLa cells were co-transfected with the indicated plasmids and T7EI
genotyping assays were carried out 3 days later. T7EI products diagnostic for indel footprints left after NHEJ-mediated DSB repair are pinpointed by the flat
arrowhead
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LUMC0044iCtrl44 and LUMC0044iCtrl44.9 were cultured in pluripotent stem cell
(PSC) growth medium in the presence of irradiated ICR mouse embryonic fibro-
blasts (MEFs), and mechanically passaged by a cut and paste method. The PSC
growth medium consisted of DMEM/F12 medium with GlutaMax, 20% KnockOut
Serum Replacement (KOSR), 10 mM non-essential amino acids (NEAAs), 25 Uml
−1 penicillin, 25 μg ml−1 of streptomycin (all from ThermoFisher Scientific), and
10 ng ml−1 of basic fibroblast growth factor (bFGF; Peprotech). PSCs were cultured
at 37 °C in an humidified-air 5% CO2 atmosphere. The cells used in all the
experiments were mycoplasma-free. All human materials were collected based on
individual written (parental) informed consent after approval by the “Medical
Ethics Committee” of the LUMC (reference numbers: P08-087 and P13-080). The
experiments involving human materials were done in accordance with the prin-
ciples outlined in the “Declaration of Helsinki”. All animal experiments were
approved by the “Animal Experiments Committee” of the LUMC (reference
number: 12133) and were performed following the recommendations and guide-
lines set by the LUMC and the Dutch “Experiments on Animals Act”.
Recombinant DNA. The constructs AU26_pCAG.Cas9 and AU28_pCAG.
Cas9D10A express Cas9 and Cas9D10A, respectively, from the hybrid CAGGS
promoter38. The “two-in-one” plasmids AV15_pCAG.Cas9.gRNAS1 and
AV44_pCAG.Cas9D10A.gRNAS1 encode Cas9 and Cas9D10A, respectively, together
with the AAVS1-targeting gRNAS1. To serve as a negative control, construct
AV13_pCas9.gRNANT expresses Cas9 and the non-targeting gRNANT. This gRNA
is irrelevant in human cells as it addresses Cas9 proteins to the recognition
sequence of the S. cerevisiae I-SceI homing endonuclease. The annotated maps and
full-length nucleotide sequences of AU26_pCAG.Cas9, AU28_pCAG.Cas9D10A,
AV15_pCAG.Cas9.gRNAS1, AV44_pCAG.Cas9D10A.gRNAS1, AV13_pCas9.
gRNANT, and AT61_pCas9H840A can be found in the Supplementary Figs. 17–22,
respectively). Likewise for the DMD-targeting donor plasmids AL05_pDonorDMD
(Addgene #100284), AL62_pDonorDMD.TS (Addgene #100287), AC62_pDo-
norDMD.TS.DR (Addgene #100288), and AZ28_pDonorDMD.TS.IR (Supplementary
Figs. 23–26, respectively), the AAVS1-targeting donor constructs AX44_pS.
DonorS1 (Addgene #100289; Supplementary Fig. 27), AX53_pS.DonorS1.TS
(Addgene #100290; Supplementary Fig. 28) and the CCR5-targeting donor plas-
mids AY42_pS.DonorR5 (Addgene #100291; Supplementary Fig. 29) and AY10_pS.
DonorR5.TS (Addgene #100292; Supplementary Fig. 30). The plasmids hCas9 (ref.
39; #41815) and hCas9_D10A39 (#41816), herein named pCas9 and pCas9D10A,
respectively, were obtained from the Addgene repository. The constructs
gRNA_Cloning Vector39 (#41824), gRNA_AAVS1-T2 (ref. 39; #41818), and
gRNA_GFP_T2 (ref. 39; #41820), herein called pgRNAEmpty, pgRNAS1, and
pgRNAGFP1, respectively, were also acquired from Addgene. The plasmid
pgRNAEmpty expresses no gRNA, whereas pgRNAS1 and pgRNAGFP1 express
gRNAs addressing Cas9 proteins to AAVS1 and EGFP sequences, respectively. The
gRNA expressing plasmids AL08_pgRNADMD (Addgene #100293),
AD19_pgRNAS1.2, AD13_pgRNAS1.3, L06_pgRNAOUT.1, AA44_pgRNAOUT.2,
X32_pgRNAIN.1, AA48_pgRNAIN.2, AY22_pgRNAR5.1 (Addgene #100294), and
AY23_pgRNAR5.2 (Addgene #100295), were assembled by inserting the annealed
oligonucleotides described in the Supplementary Table 1 into the BveI-digested
gRNA acceptor construct S7_pUC.U6.sgRNA.BveI-stuffer40. The plasmids
AM51_pUC.U6.gRNANT, herein called pgRNANT and Z46_pgRNAGFP2 encoding
an irrelevant gRNA and an EGFP-specific gRNA, respectively, have been described
before40. The AAVS1-targeting donor constructs pSh.AAVS1.eGFP and pAdV.
donorS1/T-TS, herein named pDonor.ES1 and pDonor.ES1.TS, respectively, have been
described elsewhere6, 41. The additional set of isogenic donor plasmids pDonorS1,
pDonorS1.1×TS, and pDonorS1.TS contain the AAVS1-targeting module cloned in
the pMOLUC vector backbone (Addgene #12514). The pDonorS1 plasmid has no
gRNAS1 target sites, whereas pDonorS1.1×TS and pDonorS1.TS have one and two
gRNAS1 target sites, respectively, next to their AAVS1-targeting module. The
AX35_pDonor.TurqS1 and AX28_pDonor.TurqS1.TS have the same composition of
pDonorS1 and pDonorS1.TS except that they contain amTurquoise2 ORF in place of
that of EGFP. The AT58_pDonor.37S1 and AE32_pDonor.37S1.1×TS share the same
EGFP-encoding expression unit present in pDonorS1 and pDonorS1.1xTS, respec-
tively. However, they differ from pDonorS1 and pDonorS1.1xTS in the spacing
between their regions of homology (Supplementary Fig. 5a, b). The final set of
AAVS1-targeting donor plasmids AV11_pDonor.EPS1 (Addgene #100296) and
AV09_ pDonor.EPS1.TS (Addgene #100297) have the same composition of pDo-
norS1 and pDonorS1.TS, respectively, except that they encode PuroR.T2A.EGFP in
place of EGFP (Supplementary Fig. 31). The annotated maps and DNA sequences
of the constructs generated for this study were assembled with the aid of SnapGene
3.3.4. Where indicated, plasmid pcDNA3.1 (ThermoFisher Scientific) was used as
carrier DNA in transfection experiments.
Cell Transfections. One day before transfection, HeLa cells, H27 cells, and 293
T cells were seeded in wells of 24-well plates (Greiner Bio-One; Supplementary
Tables 2–20). The transfections were initiated by mixing each of the appropriate
plasmids together with 1 mgml−1 of polyethyleneimine (PEI, Polysciences) in 50 μl
of a 150 mM NaCl solution (Merck). After ~10 s under vigorous vortexing, the
transfection mixtures were incubated for 15 min at room temperature, after which
they were directly added to the cell cultures (Supplementary Tables 2–20). At
3 days post-transfection, the transfection efficiencies were determined by EGFP-
directed flow cytometry. Subsequently, the cells were sub-cultured for at least
2 weeks, for the removal of episomal exogenous DNA, after which stable trans-
fection levels were determined by EGFP-directed flow cytometry.
Prior to the transfection of PSCs, the cells were adapted to passaging as single
cells by using TrypLE Select (ThermoFisher Scientific) and 10 µM of the Rho kinase
inhibitor Fasudil (LC Laboratories). After 2 to 5 single-cell passages, transfections
based on Lipofectamine (ThermoFisher Scientific) were initiated using different
experimental conditions as detailed in Supplementary Tables 21 and 22. In general,
single-cell suspensions were generated and incubated for 5–10 min in Opti-MEM
(ThermoFisher Scientific) containing the relevant DNA mixtures and a specific
Lipofectamine formulation (Supplementary Tables 21 and 22). Next, the cell
suspensions were seeded on 1 day-old MEF cultures containing PSC growth
medium supplemented with 10 µM Fasudil and lacking antibiotics. At 24 h post-
transfection the medium was replaced by complete PSC growth medium. After
3–4 days post-transfection, the PSCs were harvested and the transfection
efficiencies were determined by EGFP-directed and TRA-1-81-directed flow
cytometry. A fraction of the transfected PSCs were seeded and let to divide on MEF
cultures for an additional period of 7 to 10 days, after which stable transfection
levels were determined by EGFP-directed and TRA-1-81-directed flow cytometry
(see below for details).
Adenoviral vectors. The production, purification and titration of adenoviral
vector particles AdVΔ2P.Cas9.F50 and AdVΔ2U6.gRNAS1.F50, herein dubbed AdV.
Cas9 and AdV.gRNAS1, respectively, have been specified before42. The same
methods were applied to generate and characterize AdV.Cas9D10A particles. The
genome of AdV.Cas9D10A differs from that of AdV.Cas9 exclusively at codon 10 of
the Cas9 ORF.
T7 endonuclease I-based genotyping assay. Genotyping assays based on the
detection of indels by the mismatch-sensing T7 endonuclease I (T7EI) were used
for establishing targeted DSB formation activity at AAVS1. To this end, 293 T cells
were transfected using PEI as indicated in Supplementary Table 2. At 3 days post-
transfection, cell pellets were collected for subsequent genomic DNA extraction.
Genomic DNA was extracted by using the DNeasy Blood & Tissue kit (Qiagen)
according to the manufacturer’s instructions. The target region was amplified by
PCR with GoTaq G2 Flexi DNA Polymerase (Promega) following the manu-
facture’s recommendations. The composition of the PCR mixtures and the PCR
cycling parameters are specified in Supplementary Tables 23 and 24, respectively.
Next, the resulting 403 bp amplicons were subjected to T7EI assays42. In brief, PCR
amplicons were first denatured and reannealed by applying the thermocycler
program presented in Supplementary Table 25. Afterwards, 10-μl samples were
incubated at 37 °C for 17 min in a 15-μl solution containing 1.5 μl of 10 × NEBuffer
2, 0.5 μl of 10 U μl−1 T7EI (New England Biolabs) and Milli-Q water. After agarose
gel electrophoresis, the DNA fragments were stained with ethidium bromide and
were imaged by using a Molecular Imager Gel-Doc™ XR+ apparatus together with
the ImageLab 4.1 software (both from Bio-Rad).
Detection of DSBs after AdV-mediate delivery of RGNs. Hela cells were seeded
in wells of 24-well plates at a concentration of 6 × 104 cells per well. The next day,
they were transduced with different amounts and combinations of adenoviral
vectors encoding Cas9, Cas9D10A, or gRNAS1 (Supplementary Fig. 1). Mock-
transduced cells and cells transduced exclusively with each of these vectors alone
served as negative controls. Transduction experiments were carried out in duplicate
to generate parallel samples for genotyping and western blot analysis. At 3 days
post-transduction, genomic DNA was extracted and T7EI-based genotyping assays
were performed as detailed under the previous section. Likewise, at 3 days post-
transduction, protein lysates were prepared under ice-cold conditions for western
blot analysis as follows. The cells were first washed twice with phosphate-buffered
saline (PBS; pH 7.4), after which 60 μl of lysis buffer consisting of 10 mM Tris-HCl
(pH 7.5), 1% (v/v) Nonidet P-40, 150 mM NaCl, 0.1% sodium dodecyl sulphate
(SDS), and 10 mgml−1 sodium deoxycholate, was added onto the cells for 25 min
under gentle plate tilting. The lysis buffer was supplemented with the protease
inhibitors present in the cOmpleteTM, Mini Protease Inhibitor Cocktail Roche-
11836153001 (Sigma-Aldrich). Protein concentrations were determined by using
the BCA protein assay kit (ThermoFisher Scientific) and a Precisely 1420 Multi-
label Plate Counter (PerkinElmer) with the absorption wavelength set at λ= 545
nm. Next, 5-μg protein samples were diluted in bromophenol blue-containing
loading buffer consisting of 187.5 mM Tris (pH 6.8), 30% (v/v) glycerol, 9% (w/v)
SDS, and 7.5% (v/v) β-mercapthoethanol. Next, the protein samples were heated at
95 °C for 5 min and were resolved through a SDS-8% polyacrylamide gel. After
overnight electro-blotting onto Immobilon-P membranes (Millipore), the sub-
sequent blocking, antibody incubation and chemiluminescence protein detection
steps, were performed essentially as detailed elsewhere43 using a monoclonal
antibody specific for S. pyogenes Cas9 (Diagenode; clone 22B5) and a goat anti-
mouse horseradish peroxidase-conjugated IgG (Santa Cruz; sc-2005). These pri-
mary and secondary antibodies were diluted 1:2000 and 1:10,000 in blocking
buffer, respectively. To provide for an internal protein loading control, an antibody
specific for the α/β tubulin heterodimer (Cell Signalling Technology; 2148) was
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combined with the aforementioned secondary antibody. These primary and sec-
ondary antibodies were diluted 1:5000 and 1:10,000 in blocking buffer, respectively.
Sanger sequencing. The amplicons specific for translocation events between
AAVS1 and DMD sequences (Supplementary Fig. 1e) and for AAVS1-exogenous
DNA junctions (Supplementary Fig. 8) were amplified, isolated and purified from
agarose gel by using the JETquick Gel Extraction Spin kit (Genomed) according to
the manufacturer’s recommendations. The PCR mixtures and cycling conditions
used are presented in Supplementary Tables 23 and 24, respectively. Next, the
recovered fragments were inserted into pJET1.2/blunt cloning vector provided in
the CloneJET PCR Cloning Kit (ThermoFisher Scientific) following the manu-
facturer’s instructions. After transformation, randomly selected clones were grown
and subjected to Sanger sequencing (Baseclear, Leiden, the Netherlands). The
AAVS1-specific PCR products derived from randomly selected iPSC clones (Fig. 3f)
were purified and subjected to Sanger sequencing for identifying indel footprints
generated after RGN activity. All nucleotide sequence reads were aligned and
analyzed with the aid of AlignX, Vector NTI Advance R_11.5.0 software. The
Sanger sequencing chromatograms were generated by using the Chromas Lite
2.1.1 software (Technelysium Pty).
Flow cytometry. The frequencies of cells expressing EGFP, mTurquoise2 and/or
the TRA-1-81 antigen, characteristic of uncommitted PSCs, were determined by
using a BD LSR II flow cytometer (BD Biosciences). The TRA-1-81 labeling was
carried out by incubating single-cell suspensions of PSCs with a phycoerythrin-
conjugated TRA-1-81 antibody (eBioscience) diluted 1:100 in a buffer consisting of
PBS supplemented with 0.5% BSA and 2mM ethylenediaminetetraacetic acid
(EDTA). After an incubation period of 30 min at 4 °C in the dark, excess antibody
was removed by thorough successive washes with large volumes of the afore-
mentioned buffer. Data was analyzed with the aid FlowJo 7.2.2 software (Tree Star).
Non-transfected cells were used to set background fluorescence levels. At least
10,000 events, each representing a single viable cell, were measured per sample.
PCR analyses of gene-editing experiments. The composition of the PCR mix-
tures and thermocycling parameters used for the analyses of genome-modifying
events are discriminated in the Supplementary Tables 23, 24, 26 and 27. These
analyses were performed on whole target cell population as well as on individually
sorted cells. The sorting of EGFP+ HeLa and 293 T cells was conducted by using a
BD FACSAria III flow cytometer (BD Biosciences) after sub-culturing transfected
cell populations for more than 20 days. EGFP+ cells were collected in a 1:1 mixture
of regular culture medium containing 2 × penicillin–streptomycin (ThermoFisher
Scientific) and FBS. The sorted, EGFP+ cells, were seeded at a density of 0.3 cells
per well in wells of 96-well plates (Greiner Bio-One). To increase the efficiency of
cell cloning, the culture media were supplemented with 50 μM α-thioglycerol and
20 nM bathocuprione disulphonate (both from Sigma-Aldrich)44. At ~3 weeks
after seeding, single cell-derived clones were randomly collected for genomic
DNA analysis by junction PCR with the Phire Tissue Direct PCR Master Mix
(ThermoFisher Scientific) according to the manufacturer’s recommendations. The
junction PCR screening of randomly selected puromycin-resistant iPSC colonies
was also done by direct PCR. The various direct PCR conditions used in each
experiment are specified in Supplementary Tables 26 and 27.
Generation of iPSCs. Human fetal fibroblasts were isolated and reprogrammed to
iPSCs as detailed elsewhere45. In brief, the cell reprogramming was induced by
transducing 2 × 104 human fetal fibroblasts seeded in a 12-well plate with the
multi-cistronic lentiviral vector LV.RRL.PPT.SF.hOKSM.idTomato.-preFRT45, 46.
The vector particles, encoding OCT3/4, KLF4, SOX2, and cMYC, were removed
24 h later. At 6 days post-transduction, the cells were harvested and 104 of them
were seeded on a 10-cm dish with 2 × 106 MEFs cultured in KOSR PSC growth
medium (ThermoFisher Scientific). The medium was replenished every other day
until the appearance of ESC-like colonies. The resulting iPSCs were subsequently
cultured on irradiated ICR MEFs in complete PSC growth medium. The iPSC clone
LUMC0044iCtrl44, containing a single provirus, was selected. Subsequently, the
chromosomally inserted provirus was removed through hcAd.FLPe.F50-mediated
expression of FLPe recombinase43. To this end, LUMC0044iCtrl44 iPSCs were
transduced with hcAd.FLPe.F50 at a multiplicity of infection (MOI) of 20 trans-
duction units/ml. The resulting provirus-free iPSC clone LUMC0044iCtrl44.9 was
characterized by immunofluorescence microscopy, COBRA-FISH karyotyping and
teratoma assays as described below.
Differentiation of iPSCs. The in vitro spontaneous differentiation of iPSCs into
the three embryonic germ layers was triggered by culturing clumps of iPSCs on
coverslips coated with Vitronectin XF (StemCell Technologies). The cells were
incubated in PSC growth medium devoid of bFGF and containing 20% FBS in
place of KOSR. The medium was replenished every 2 days. After 3 weeks under
differentiation conditions, the cells were stained for the endoderm, mesoderm and
ectoderm markers alpha-fetoprotein (AFP), platelet and endothelial cell adhesion
molecule 1 (CD31), and tubulin beta 3 class III (TUBB3), respectively. The in vivo
differentiation of iPSCs into cell types belonging to the three different embryonic
germ layers was assessed through teratoma formation assays. To this end,
immunodeficient female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice (8–12 weeks
old) were injected subcutaneously with 1 × 106 cells. After 10–16 weeks post-
injection, teratomas were isolated and fixed in 4% paraformaldehyde (PFA) and,
subsequently, embedded in paraffin and sectioned. Finally, pigmented
epithelium (ectoderm), trachea-like epithelium (endoderm), and cartilage
(mesoderm) present in iPSC-derived teratomas were identified by
hematoxylin–phloxine–saffron (HPS) staining and standard visible light
microscopy.
Detection of apoptosis. Two days after transfecting H1 ESCs with Lipofectamine
3000™ (ThermoFisher Scientific) mixed with different construct combinations
(Supplementary Table 22), the frequencies of apoptotic cells were measured by
using Annexin-V Apoptosis Detection Kit-eFluro 450 according to the manu-
facturer’s instructions (ThermoFisher Scientific). H1 ESC cultures treated for 2 h
with 1 μg ml−1 of staurosporine, stained, or not stained with fluorochrome-
conjugated Annexin V, served as positive and negative controls, respectively.
Immunofluorescence microscopy. The acquisition of pluripotency markers (i.e.,
TRA-1-81, SSEA4, OCT3/4, and NANOG) and differentiation markers (i.e., AFP,
CD31, and TUBB3) by iPSCs and iPSC-derived cells, respectively, was assessed via
immunofluorescence staining. In brief, cells were first fixed for 15 min in 4% PFA.
After several washes with PBS, they were exposed for 1 h to a PBS solution con-
taining 0.1% Triton X-100 and 4% normal swine serum (NSS; Jackson Immu-
noResearch). Next, the cells were incubated overnight at 4 °C with primary
antibodies directed against TRA-1-81 (1:125; Biolegend Cat. #330702), SSEA4
(1:30; Biolegend Cat. #330402), OCT3/4 (1:100; Santa Cruz Biotechnology Cat. #sc-
5279); NANOG (1:500; R&D Systems Cat. #963488); AFP (1:25; Quartett Cat.
#2011200530), CD31 (1:100; Dako Cat. #M0823), and TUBB3 (1:4000; Covance
Cat. #MMS-435P). These antibodies were diluted in PBS containing 4% NSS. After
three 10-min washes with PBS containing 0.05% Tween-20, the specimens were
incubated for 1 h in the dark with secondary antibodies (ThermoFisher Scientific)
conjugated with Alexa Fluor 488 (1:500) or with Alexa Fluor 568. For the detection
of pluripotency and differentiation markers, the Alexa Fluor 568 secondary anti-
body was applied at 1:200 and 1:500 dilutions, respectively. Nuclei were stained for
5 min in the dark with 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI;
ThermoFisher Scientific). The DAPI was diluted 1:1000 and 1:200 in PBS for the
detection of nuclei of pluripotent and differentiated cells, respectively. Finally, the
specimens were rinsed with sterile Milli-Q water (Millipore) and were mounted
with Mowiol (Calbiochem). The in vitro PSC differentiation analyses were per-
formed with an IX51 inverse fluorescence microscope equipped with a XC30
Peltier-cooled digital color camera (Olympus) or a Confocal laser scanning
microscope TCS SP8 (Leica). The images were processed with the aid of CellF 3.4
imaging software (Olympus) or LAS AF software (Leica).
COBRA-FISH karyotyping. Combined binary ratio labeling (COBRA)-FISH
analysis was carried out for determining the karyotype of iPSCs essentially fol-
lowing the instructions indicated in a previously published protocol47. In short,
slides with metaphase chromosomes from iPSCs were pre-treated with RNase I
(Roche; 100 μg ml−1 in 2 × SSC) and pepsin (Sigma-Aldrich; 0.005% in 0.01M
HCl) at 37 °C for 10 min and 5 min, respectively. After a 10-min fixation with 1%
(v/v) formaldehyde in PBS, the specimens were dehydrated by sequential 3-min
incubations in 70%, 90% and 100% ethanol. Next, whole-chromosome painting
probes, labeled with the fluorescent dyes diethylaminocoumarin, Cy3, Cy5, and
rhodamine green using the Universal Linkage System (ULS) kit (Kreatech Bio-
technology), were applied to the air-dried slides. After a denaturation step at 80 °C
for 45–90 s, DNA hybridizations were let to proceed in a humidified chamber at 37
°C for 2 days. The unbound probes were removed by a series of post-hybridization
washes and the samples were subsequently dehydrated by exposing them to
increasing concentrations of ethanol as aforementioned. Finally, the chromosome
specimens were sealed and counterstained with Citifluor AF1 mounting solution
(Citifluor Ltd.) containing 500 ng ml−1 of the DNA dye DAPI. Digital images were
acquired with the aid of a Leica DMRA fluorescence microscope coupled to a CCD
camera.
Colony-formation assays. In addition to flow cytometric analysis, stable trans-
fections resulting from gene targeting experiments with pDonor.EPS1 and pDonor.
EPS1.TS were also assessed by colony-formation assays. These assays were applied
to puromycin-resistant HeLa and PSC colonies by using, respectively, a standard
Giemsa staining and the leukocyte AP kit for detecting alkaline phosphatase (AP)
activity (Sigma-Aldrich). These colonies were derived from cell cultures initially
exposed to pDonor.EPS1 and pCAG.Cas9.gRNAS1 (standard setting) or to pDonor.
EPS1.TS and pCAG.Cas9D10A.gRNAS1 (Nick2 setting). In brief, at 20 days post-
transfection, HeLa cells were seeded at densities of 1 × 103 and 1 × 104 cells per
10-cm dish (Greiner Bio-One) in the presence of 1 μg ml−1 of puromycin.
Puromycin-resistant HeLa cell colonies were identified by Giemsa staining 9 days
later. Next to this, at 3–4 days post-transfection PSCs were seeded at a density of
2–3 × 105 cells per MEF culture and, 1 day later, were exposed to puromycin at a
final concentration of 1 μg ml−1. After 5 days under puromycin selection was
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assessed by using the aforementioned AP detection kit following the manu-
facturer’s instructions.
Southern blot analysis. Genomic DNA was extracted from individual
EGFP+/mTurquoise2+ HeLa cell clones and from a control EGFP+ HeLa cell clone
according to a standard organic solvent-based protocol as follows. The cells were
collected and incubated overnight at 50 °C in 250 μl of lysis buffer containing
10 mM Tris-HCl (pH 8), 25 mM EDTA (pH 8), 0.5% (w/v) SDS, and 100 mM
NaCl. Prior to use, the lysis buffer was supplemented with freshly added proteinase
K (ThermoFisher Scientific) at a final concentration of 0.1 μg μl−1. The resulting
cell lysates were extracted twice by gentle pipetting in a 1:1 mixture with buffer-
saturated phenol:chloroform:isoamyl alcohol (25:24:1). The aqueous phase was
recovered and was subsequently subjected to one additional extraction cycle by
gentle pipetting in a 1:1 mixture with chloroform. Next, the chromosomal DNA
present in the aqueous phase was precipitated in 2.0 and 0.5 volumes of ethanol
and 7.5 M ammonium acetate (pH 5.5), respectively. The recovered genomic DNA
pellets were washed with 70% (v/v) ethanol, gently air-dried, and were finally
dissolved in DNase-free sterile water at a concentration of 1–2 μg μl−1. Subse-
quently, DNA samples (10 μg each) were digested overnight with BlpI (New
England BioLabs) and were resolved through a 1.0% agarose gel in 1 × Tris-acetate-
EDTA buffer. The DNA was transferred by capillary action onto an Amersham
Hybond-XL membrane (GE Healthcare Life Sciences) using an alkaline transfer
buffer consisting of 0.4 N NaOH and 1M NaCl. After overnight transfer, the
membrane was neutralized with a pH 7.2 solution containing 0.5 M Tris-HCl and
1M NaCl. The EGFP-specific and mTurquoise2-specific probes (994 bp each) were
isolated from agarose gel after AgeI/HindIII double digestion of AA63_pDonorS1
and AX28_pDonor.TurqS1, respectively. The purified DNA probes were radi-
olabeled with [α-32P]dATP (GE Healthcare Life Sciences) by using the DecaLabel
DNA labeling Kit following the manufacturer’s instructions (ThermoFisher
Scientific). The Pre-hybridization and hybridization steps, 2 h and overnight,
respectively, were performed at 65 °C in Rapid-Hyb Buffer (GE Healthcare). Next,
the membrane was washed at 65 °C once with a 2 × SSC solution supplemented
with 0.1% (w/v) SDS (20 min) and twice with a 0.5 × SSC solution supplemented
with 0.1% (w/v) SDS (20 min each). Finally, the membrane was gently air-dried,
wrapped in Saran film and exposed to an Amersham Hyperfilm MP (GE
Healthcare). The autoradiogram film was obtained by using standard developing
solutions.
Statistical analyses. The researchers were not blinded to sample allocation during
experiments and data analyses. One-way ANOVA combined with Bonferroni tests
were used for the statistical analyses of data sets obtained from three independent
experiments comparing the performance of donors with no, one, or two gRNA
target sites (P< 0.05 was considered significant). The IBM SPSS Statistics 23 soft-
ware package was employed for these analyses. The comparison of data sets
retrieved from standard and in trans paired nicking gene targeting experiments was
performed by applying two-tailed Student’s t-tests (P< 0.05 was considered sig-
nificant). The GraphPad Prism 6 software package was used for these analyses.
Restriction-fragment length analyses. Amplicons spanning the AAVS1 and
CCR5 target sites, and the BlpI polymorphism in the mTurquoise2 coding sequence
were generated with the PCR reagents and subsequently exposed to the restriction
enzymes specified in Supplementary Table 28. The corresponding primers and
PCR cycling conditions are indicated in Supplementary Tables 23, 24, 26, and 27.
Data availability. All relevant results generated in this study are available within
the paper and respective Supplementary Information or are available from the
corresponding author on reasonable request. Sanger sequencing chromatograms
are deposited in FigShare at 10.6084/m9.figshare.5208766.
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